Clinical trials
Phase 1/2 Thyroid Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| Eli Lilly and Company | 2 |
| National Cancer Institute (NCI) | 2 |
| TransThera Sciences (Nanjing), Inc. | 2 |
| Turning Point Therapeutics, Inc. | 2 |
| Alume Biosciences, Inc. | 1 |
| Arvinas Inc. | 1 |
| DualityBio Inc. | 1 |
| Genexine, Inc. | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 31 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Neoplasms | 11 |
| Colonic Neoplasms | 10 |
| Lung Neoplasms | 10 |
| Head and Neck Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Stomach Neoplasms | 8 |
| Melanoma | 7 |
| Ovarian Neoplasms | 7 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.